Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
RBC Capital reiterated an Outperform rating and $30.00 price target on Ocular Therapeutix (OCUL), pointing to meaningful upside from the current share price and continued confidence in the upcoming SOL-1 pivotal readout. The firm highlighted recent share underperformance, proprietary trial modeling, a new commercial hire, and the company’s decision…
Piper Sandler lowered its price target on Snap Inc. to $8 from $10 and kept a Neutral rating after the company’s recent results. The firm cited softer daily active user trends and higher expected expenses as the rationale, even as revenue and EBITDA modestly outperformed expectations and Snap’s subscription business showed momentum. Management guid…
Lake Street Capital Markets reduced its 12-month price target on LifeVantage Corporation (LFVN) to $5.00 from $12.00 following weaker-than-expected second-quarter results and lower guidance. The firm kept a Buy rating even as the company reported an EPS in line with forecasts but missed revenue, took an inventory obsolescence charge tied to its Min…
RBC Capital has reduced its price target on Arm Holdings to $130 from $140 yet left its Outperform rating intact. The new target implies roughly 11% upside from Arm's quoted share price, while third-party data indicates the stock is trading near fair value. RBC pointed to a softer outlook for fiscal Q4 royalty growth as a near-term headwind, but em…
Addentax Group Corp shares rose sharply in premarket trading after the company revealed a proposed acquisition of the offshore wealth management and cross-border services business of Hong Kong-based Riches Group. Management says the deal would accelerate Addentax’s expansion into offshore financial markets and add AI and digital currency offerings,…
BMO Capital Markets raised its price objective for Alphabet to $400 from $343 and maintained an Outperform rating, designating the stock a Top Pick. The firm pointed to stronger-than-expected fourth-quarter 2025 results - led by Search and Google Cloud - and highlighted progress in AI adoption and material cost-to-serve improvements. Other analysts…
BMO Capital raised its 12-month price target on Moelis & Company to $78 from $75 and left its Market Perform rating in place after the firm reported fourth-quarter 2025 adjusted EPS of $1.13, beating BMO's $1.09 estimate and well ahead of consensus figures. Revenue strength and a normalization of compensation metrics underpinned the move, though ri…
RBC Capital analyst Ken Herbert views the roughly 14% pullback across defense technology stocks as an opportunity to add exposure, favoring KBR and Mercury Systems. The analyst cites valuation metrics, recent contract awards for KBR, and sector developments such as RTX volume plans, while flagging supply chain timing risks and budgetary confusion t…
BMO Capital has reduced its price objective for Crown Castle to $91 from $97 while keeping an Outperform rating, citing a larger-than-expected impact from DISH Network on the company’s 2026 guidance. UBS also trimmed its target to $105 from $116 after Crown Castle posted stronger-than-expected fourth-quarter 2025 results.
JPMorgan raised its price target on Eli Lilly to $1,300 from $1,150 and kept an Overweight rating after the company reported strong fourth-quarter results and issued fiscal 2026 guidance. The bank cited a "sustainable runway for significant growth" driven by share gains in the underpenetrated obesity and type 2 diabetes markets, aligning with Lilly…
JPMorgan raised its price target on Alphabet to $395 from $385 while keeping an Overweight rating after the company reported robust fourth-quarter results. The update follows strong year-over-year revenue gains led by Search and Google Cloud, a materially larger 2026 capital expenditure outlook and a substantial Cloud backlog, all supported by a ca…
RBC Capital cut its price objective on Equifax Inc. to $222 from $250 while keeping an Outperform stance, noting both near-term market concerns and business drivers that could support revenue growth into 2027. The revised target is said to be close to InvestingPro's Fair Value assessment. RBC highlighted the Online Brand Building Business as a cata…
BMO Capital reduced its price objective on PTC Inc. to $189 from $219 while retaining an Outperform rating after the company's first-quarter fiscal 2026 report. The firm described the quarter as "okay," highlighted sizable contracted deferred ARR as reassurance for back-half revenue acceleration, and pointed to strong profitability and revenue grow…
A regional court in Munich has ordered Renault to cease sales of its Megane and Clio models after determining the automaker does not hold the required license to use specific ethernet network cable connections, the court's decision said. The order will not take effect unless Broadcom, the U.S. technology group that brought the suit, posts a deposit…
ConocoPhillips is trading near recent highs but still looks attractive as a cash-generative upstream operator. Strong free cash flow, modest leverage and an explicit plan to prioritize returns to shareholders make a case for a long trade sized for upside from steady fundamentals rather than a commodity call. Trade plan included for a 180-trading-da…
uniQure NV’s stock rose modestly in premarket trading after the company released preliminary Phase I/IIa results for AMT-191, a gene therapy candidate for Fabry disease. All 11 treated patients demonstrated raised α-galactosidase A activity, with the highest-dose cohort achieving 27.7- to 223.7-fold increases over normal. Six patients met criteria …
A Palestinian woman who left Gaza with her children for medical treatment returned through the recently reopened Rafah crossing to reunite with her husband, only to find large-scale destruction, no electricity and plans to live in a tent. The limited reopening of Rafah has allowed only a small number of people to cross, and those returning report i…
Gordon Douglas S, a director at Waterstone Financial (NASDAQ: WSBF), disposed of 33,716 common shares in two transactions totaling $619,832. The trades took place on February 4 and 5, 2026, as the stock traded near its 52-week high. Following the sales, the director's direct stake stands at 566,418 shares. Waterstone carries a market capitalization…
Hub Group's shares plunged 23% in premarket trading after the logistics firm disclosed an accounting mistake that understated purchased transportation costs and accounts payable. The error, pegged at $77 million for the first nine months of 2025, has prompted the company to delay full fourth-quarter results and restate prior quarters. Stifel and Ba…
TD Cowen increased its price target on Bloom Energy Corp. (BE) to $160 from $105 while keeping a Hold rating, pointing to accelerating power demand from data center and commercial and industrial customers that has helped drive a 140% backlog increase. The company's 2026 revenue guidance sits 25% above consensus, and recent quarterly results topped …
BMO Capital reduced its price target for FirstService Corp (FSV) to $202 from $209 while retaining an Outperform rating. The adjustment follows the company’s fourth-quarter 2025 results, which BMO described as a beat driven by stronger-than-expected adjusted EBITDA in the FirstService Residential segment and in-line performance from FirstService Br…
BMO Capital reduced its price target on Novo Nordisk to $45.00 from $57.00 while keeping a Market Perform rating, citing a "challenging quarter" and "very real headwinds." The stock has tumbled sharply in recent trading and faces guidance pointing to a year-over-year sales decline at constant exchange rates, even as recent quarterly results beat ex…
Goldman Sachs has downgraded Atlas Copco AB from Buy to Neutral and cut its price target to SEK184.00 from SEK186.00. The bank points to foreign exchange and tariff pressures that it expects will counterbalance growth in the company’s Vacuum Technique unit, even as that division benefits from a projected semiconductor recovery. Valuation metrics an…
SmartKem Inc. reported that it has settled roughly $2.0 million of outstanding accounts payable by issuing equity securities, a move that sent the company's stock up 11.5%. The liabilities were converted into a mix of common shares and pre-funded warrants at an implied conversion price of $2.75 per share, and the securities were issued in a private…
UBS has raised its projection for Eurozone growth in 2026 to 1.3% from an earlier estimate, responding to a stronger GDP outturn in 2025. The bank points to unexpectedly resilient fourth-quarter momentum, driven in part by domestic demand, and expects fiscal stimulus for defence and infrastructure - notably in Germany - to provide a further boost t…
